mRNAワクチン製造プロセス開発に適した高品質の酵素を発売 タカラバイオ株式会社は、mRNAワクチン製造におけるプロセス開発に適したHigh Quality（HQ）グレード（注1）のmRNA製造用酵素「Pyrophosphatase (inorganic),HQ」を8月31日より新発売します。 「Pyrophosphatase ...

今回開発した新Direct-SATORI法では、検査試薬および手順を一から最適化することで、mRNA薬剤から遺伝子を効率よく取り出す工程をSATORI法に統合するとともに、血液中に含まれる多様な成分による影響を最小限に抑える独自の検査手法を構築しまし ...

Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...

The 3rd mRNA Process Development and Manufacturing Summit returns to Boston this September, poised to help you implement high throughput process development, scale-up mRNA synthesis and purification, ...

新型コロナウイルスワクチンの実用化で医薬メッセンジャーRNA（mRNA）が注目されています。これは、目的のタンパク質の情報を持つmRNAを人工的に合成し、投与することで病気の治療や予防をしようというものです。この医薬mRNAの品質を管理するためには ...

Enhance Speed, Purity & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indication Returning to Frankfurt, ...

Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...

LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...

The corona pandemic has ensured that the term "mRNA" is now also known to a large public beyond laboratories and lecture halls. However, the molecule is much more than an important component of a ...

Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in ...

A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds.